Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00233636
Status:
WITHDRAWN
Last Update Posted:
2011-01-27
First Post:
2005-10-04
Brief Title:
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A 2 Part Phase 2 Trial to Evaluate ZD1839 Iressa Radiotherapy in Patients wLocally Advanced Inoperable Squamous Cell Carcinoma of the Head Neck
Status:
WITHDRAWN
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None